2
19 forecasters
Will Moderna Rank Among the Top 5 Biotech Companies Globally by Market Cap Before the End of 2028?
10%chance
Top Key Factors
Significant falling of Moderna's market cap year-on-year since peak in 2021
Decreases Likelihood
Declining global demand for Moderna's Covid-19 vaccine
Decreases Likelihood
Intense competition in the mRNA vaccine and therapeutic market
Decreases Likelihood